To our knowledge, no studies have investigated the role of DNA methylation alterations in PHLDA2 dysregulation in cancers, except for one study conducted by Fu and colleagues, which revealed that DNA methylation status of PHLDA2 in peripheral blood was associated with breast cancer susceptibility [38]. Here, PHLDA2 is linked to breast cancer.